CORDIS
EU research results

CORDIS

English EN
European Advanced infraStructure for Innovative Genomics

European Advanced infraStructure for Innovative Genomics

Objective

Next-generation sequencing (NGS) has taken modern research by storm and consequently is one of the most important tools of modern biological and biomedical research. However, the high cost of instrumentation and reagents, the multifaceted expertise required for correct use and the legal and ethical issues hamper access to NGS technologies for many researchers. EASI-Genomics addresses those challenges by unifying the major European genome centers that provide external access to their facilities. The mission of EASI-Genomics is to facilitate access to cutting-edge DNA sequencing technologies to researchers from both academia and industry, within a framework that ensures compliance with ethical and legal requirements, as well as FAIR and secure data management. EASI-Genomics will provide fully funded access to more than 150 transnational access projects, selected through public calls and a rigorous, fair and transparent peer-review process. Each funded study will be supported from design, through sequencing, to data analysis. EASI-Genomics will provide more than 100 Tb of sequence and more than 25,000 hours of bioinformatic, analytical and data management support to the user community. As outlined in the call, EASI-Genomics will provide access to advanced methods that go beyond what is commercially available. The focus will be on more complex procedures involving short-reads, long-reads, in situ sequencing and single-cell analysis. Complex integrative projects and projects on non-human samples will also be highlighted. Finally, EASI-Genomics will support the wider NGS community to improve their quality control processes by offering open inter-laboratory comparisons allowing them to obtain ISO certification and accreditation in line with many of the EASI-Genomic partners. The EASI-Genomics project aims to build a community of practice, which leverages advanced sequencing technologies beyond country and sector borders to tackle global challenges in science.

Coordinator

FUNDACIO CENTRE DE REGULACIO GENOMICA

Address

Carrer Doctor Aiguader 88
08003 Barcelona

Spain

Activity type

Research Organisations

EU Contribution

€ 1 999 718

Participants (15)

Sort alphabetically

Sort by EU Contribution

Expand all

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

France

EU Contribution

€ 1 269 970,25

CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL

Germany

EU Contribution

€ 806 866,25

MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC)

Germany

EU Contribution

€ 764 802

KATHOLIEKE UNIVERSITEIT LEUVEN

Belgium

EU Contribution

€ 764 609

STOCKHOLMS UNIVERSITET

Sweden

EU Contribution

€ 511 132,50

UPPSALA UNIVERSITET

Sweden

EU Contribution

€ 674 443

KUNGLIGA TEKNISKA HOEGSKOLAN

Sweden

EU Contribution

€ 607 204,25

DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

Germany

EU Contribution

€ 522 338,75

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

EU Contribution

€ 176 698,75

MEDIZINISCHE UNIVERSITAT GRAZ

Austria

EU Contribution

€ 195 323,75

EUROPEAN MOLECULAR BIOLOGY LABORATORY

Germany

EU Contribution

€ 214 393,75

TARTU ULIKOOL

Estonia

EU Contribution

€ 410 489

CHARITE - UNIVERSITAETSMEDIZIN BERLIN

Germany

EU Contribution

€ 590 531,50

LGC LIMITED

United Kingdom

EU Contribution

€ 259 246,25

QIAGEN GMBH

Germany

EU Contribution

€ 223 500

Project information

Grant agreement ID: 824110

Status

Ongoing project

  • Start date

    1 February 2019

  • End date

    31 January 2023

Funded under:

H2020-EU.1.4.1.2.

  • Overall budget:

    € 9 991 267

  • EU contribution

    € 9 991 267

Coordinated by:

FUNDACIO CENTRE DE REGULACIO GENOMICA

Spain